Auxly Cannabis Financials

XLY Stock  CAD 0.04  0.01  12.50%   
We suggest to use Auxly Cannabis Group fundamental analysis to find out if markets are presently mispricing the company. Put another way this technique allows you to double-check available reported financial drivers of Auxly Cannabis Group as well as the relationship between them. We have analyzed and interpolated thirty-three available fundamental indicators for Auxly Cannabis Group, which can be compared to its peers. The stock experiences a very speculative upward sentiment. Check odds of Auxly Cannabis to be traded at C$0.0333 in 90 days. Key indicators impacting Auxly Cannabis' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio0.590.6169
Sufficiently Down
Slightly volatile
  
Understanding current and past Auxly Cannabis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Auxly Cannabis' financial statements are interrelated, with each one affecting the others. For example, an increase in Auxly Cannabis' assets may result in an increase in income on the income statement.

Auxly Cannabis Stock Summary

Auxly Cannabis competes with OrganiGram Holdings, and Tilray. Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada. AUXLY CANNABIS operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 558 people.
Foreign Associate
  USA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentCanada Stock View All
ExchangeToronto Exchange
ISINCA05335P1099
Business Address777 Richmond Street
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.auxly.com
Phone647 812 0121
CurrencyCAD - Canadian Dollar
You should never invest in Auxly Cannabis without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Auxly Stock, because this is throwing your money away. Analyzing the key information contained in Auxly Cannabis' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Auxly Cannabis Key Financial Ratios

Auxly Cannabis' financial ratios allow both analysts and investors to convert raw data from Auxly Cannabis' financial statements into concise, actionable information that can be used to evaluate the performance of Auxly Cannabis over time and compare it to other companies across industries.

Auxly Cannabis Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets411.6M379.0M450.4M331.8M261.9M275.0M
Other Current Liab1.4M7.4M1.3M712K492.0K579.8K
Net Debt55.6M103.5M175.4M179.0M142.9M150.0M
Retained Earnings(189.3M)(274.7M)(308.5M)(438.8M)(483.3M)(459.1M)
Accounts Payable20.2M27.2M30.6M33.0M41.3M43.4M
Cash44.1M21.2M14.8M14.6M16.2M15.4M
Net Receivables15.6M13.5M31.2M17.5M16.7M17.6M
Total Liab149.7M187.4M242.3M246.1M210.9M221.4M
Total Current Assets91.6M91.9M120.0M89.9M66.0M33.6M
Short Term Debt3.9M4.7M21.5M58.9M65.2M68.4M
Common Stock384.4M394.6M436.5M444.8M446.6M468.9M
Other Current Assets230K12.7M14.9M3.1M1.5M2.0M
Inventory27.1M44.2M58.9M54.5M31.4M30.3M
Long Term Debt90.9M110.5M151.4M119.8M81.4M91.7M
Long Term Debt Total95.8M119.9M168.6M134.7M154.9M99.3M
Cash And Equivalents44.1M21.2M14.8M14.6M13.2M12.5M
Intangible Assets77.4M74.3M74.2M45.5M29.9M57.7M
Other Liab19.0M23.6M22.5M20.0M23.1M19.7M
Net Tangible Assets195.8M158.2M93.1M114.0M131.1M129.9M
Net Invested Capital357.8M309.7M381.3M264.9M193.8M314.5M
Net Working Capital61.7M46.9M66.3M(2.8M)(39.0M)(37.0M)
Capital Stock384.4M394.6M436.5M444.8M446.6M450.5M

Auxly Cannabis Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense12.1M13.0M17.7M21.6M25.7M26.9M
Total Revenue8.4M50.8M83.8M94.5M101.1M106.1M
Gross Profit(3.7M)11.1M19.3M17.9M(1.9M)(1.8M)
Operating Income(61.0M)(54.0M)(42.0M)(46.8M)(42.2M)(40.0M)
Ebit(61.0M)(53.7M)(42.0M)(46.8M)(42.2M)(40.0M)
Ebitda(52.5M)(44.6M)(27.7M)(25.2M)(30.9M)(29.4M)
Income Before Tax(119.6M)(88.1M)(50.2M)(136.6M)(47.7M)(45.4M)
Net Income(108.6M)(87.4M)(45.9M)(130.3M)(44.5M)(42.3M)
Income Tax Expense(11.0M)(681K)(4.3M)(6.3M)(3.2M)(3.1M)
Cost Of Revenue12.1M39.7M64.5M76.6M103.0M108.1M
Tax Provision(11.0M)(681K)(4.3M)(6.3M)(3.2M)(3.4M)
Interest Income12.1M20.4M3.9M337K32K30.4K
Net Interest Income(8.5M)(12.6M)(16.1M)(21.2M)(25.7M)(24.4M)

Auxly Cannabis Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash(167.6M)(22.9M)(5.9M)(118K)972K535.0K
Free Cash Flow(116.9M)(53.9M)(50.0M)(11.7M)6.6M6.9M
Capital Expenditures37.8M20.7M378K9.2M1.6M1.5M
Net Income(108.6M)(87.4M)(45.9M)(130.3M)(44.5M)(42.3M)
End Period Cash Flow44.1M21.2M14.8M14.6M16.2M14.8M
Other Non Cash Items56.2M39.8M14.6M88.4M25.2M26.5M
Depreciation8.6M9.4M14.3M21.6M11.2M5.9M
Change To Inventory(24.4M)(19.5M)(6.9M)(3.2M)(5.7M)(5.9M)
Investments(75.2M)6.0M9.3M1.2M(1.6M)(1.6M)
Net Borrowings99.5M40.8M7.2M(19.6M)(17.6M)(16.7M)
Change To Netincome34.1M53.0M43.0M(506K)(581.9K)(552.8K)

Auxly Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Auxly Cannabis's current stock value. Our valuation model uses many indicators to compare Auxly Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Auxly Cannabis competition to find correlations between indicators driving Auxly Cannabis's intrinsic value. More Info.
Auxly Cannabis Group is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers . At this time, Auxly Cannabis' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Auxly Cannabis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Auxly Cannabis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Auxly Cannabis Group Systematic Risk

Auxly Cannabis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Auxly Cannabis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Auxly Cannabis Group correlated with the market. If Beta is less than 0 Auxly Cannabis generally moves in the opposite direction as compared to the market. If Auxly Cannabis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Auxly Cannabis Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Auxly Cannabis is generally in the same direction as the market. If Beta > 1 Auxly Cannabis moves generally in the same direction as, but more than the movement of the benchmark.

Auxly Cannabis Group Total Assets Over Time

Today, most investors in Auxly Cannabis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Auxly Cannabis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Auxly Cannabis growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.003336

At this time, Auxly Cannabis' Price Earnings To Growth Ratio is very stable compared to the past year.

Auxly Cannabis November 24, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Auxly Cannabis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Auxly Cannabis Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Auxly Cannabis Group based on widely used predictive technical indicators. In general, we focus on analyzing Auxly Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Auxly Cannabis's daily price indicators and compare them against related drivers.

Other Information on Investing in Auxly Stock

Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.